Using FET-PET scans to guide treatment for possible pseudoprogression in glioblastoma
Part of Cancer clinical trials.
This trial uses a special type of PET scan (FET-PET) to help doctors distinguish between pseudoprogression (a temporary reaction to treatment that can look like tumor growth on MRI) and actual tumor recurrence in people with glioblastoma. The goal is to improve management decisions and avoid unnecessary treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of glioblastoma, IDH-wildtype, WHO grade 4
- You are 18 years or older
- Your follow-up MRI (done at least 3 months after completing chemoradiation) shows new or increased enhancement within the radiation area
- Your doctor is uncertain whether this MRI finding is due to pseudoprogression or tumor recurrence
- You have not had any previous treatment for tumor recurrence
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses advanced imaging to help surgeons remove as much of a malignant brain tumor as safely possible. It may be a good fit if you have a new diagnosis of glioblastoma or a certain astrocytoma and are healthy enough for surgery.
This study is testing whether special MRI scans and blood tests can help tell the difference between true tumor growth (progression) and a treatment-related reaction called 'pseudoprogression' in people with glioblastoma. The goal is to make treatment decisions more accurate.
This Phase 2 study tests whether a special brain scan called PET-DOPA can help guide repeat radiation for glioblastoma that has come back. It aims to improve treatment planning while keeping tumors within safe radiation limits near important brain structures.
This study looks for connections between detailed brain scans and tumor genetic features in people with glioblastoma. It may help researchers find better ways to understand your tumor and tailor future care.
This trial tests whether adding a precise, MRI-guided radiation treatment to tumor-treating electric fields (TTFields) can help people with recurrent glioblastoma. You may qualify if your tumor has come back 1 to 3 times after standard therapy and you haven't had certain prior treatments.
This trial tests whether a special PET scan can tell the difference between actual tumor growth and treatment-related changes in people with aggressive brain cancer (high-grade glioma). If you have had radiation and an MRI shows a growing lesion, this study may help clarify the cause.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.